SCHEMBL2461350

SCHEMBL2461350

C(=Cc1ccc[nH]1)c1nnon1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MAPT P10636 4/20 0.36
MAPK1 P28482 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NPC1 O15118 2/20 0.33
CHEK1 O14757 1/20 0.33
HTT P42858 1/20 0.33
ALDH1A1 P00352 2/20 0.33
CYP1A1 P04798 1/20 0.32
CYP1B1 Q16678 1/20 0.32
GRIN2D O15399 1/20 0.31
GRIN3B O60391 1/20 0.31
GRIN1 Q05586 1/20 0.31
GRIN2A Q12879 1/20 0.31
GRIN2B Q13224 1/20 0.31
GRIN2C Q14957 1/20 0.31
GRIN3A Q8TCU5 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2461349 1.00 RAB9A (0.38) RAB9AL3MBTL1MAPTMAPK1SMN1; SMN2
SCHEMBL2464133 0.74 MAPT (0.52) RAB9AL3MBTL1MAPTMAPK1SMN1; SMN2
SCHEMBL2464131 0.74 MAPT (0.52) RAB9AL3MBTL1MAPTMAPK1SMN1; SMN2
SCHEMBL2461189 0.72 RAB9A (0.36) RAB9AL3MBTL1MAPTMAPK1SMN1; SMN2
SCHEMBL2461188 0.72 RAB9A (0.36) RAB9AL3MBTL1MAPTMAPK1SMN1; SMN2
SCHEMBL2465544 0.72 AOC1 (0.43)
SCHEMBL2457639 0.69 RAB9A (0.36) RAB9AL3MBTL1MAPTMAPK1SMN1; SMN2
SCHEMBL2457644 0.69 RAB9A (0.36) RAB9AL3MBTL1MAPTMAPK1SMN1; SMN2
SCHEMBL2459969 0.69 RAB9A (0.38) RAB9AL3MBTL1MAPTMAPK1SMN1; SMN2
SCHEMBL2459971 0.69 RAB9A (0.38) RAB9AL3MBTL1MAPTMAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110237633-A1 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2011-09-29 US disclosed
WO-2010068287-A2 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY ANGION BIOMEDICA CORP. (US) 2010-06-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237633-A1 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY HGF, HDGF, MET RAB9A 3044/4885L3MBTL1 3392/4885MAPT 3790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.